These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6707148)

  • 1. High-performance liquid chromatographic method for the determination of labetalol in plasma using ultraviolet detection.
    Hidalgo IJ; Muir KT
    J Chromatogr; 1984 Jan; 305(1):222-7. PubMed ID: 6707148
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitive high-performance liquid chromatographic method for the determination of labetalol in human plasma using fluorimetric detection.
    Oosterhuis B; van den Berg M; van Boxtel CJ
    J Chromatogr; 1981 Nov; 226(1):259-65. PubMed ID: 7320152
    [No Abstract]   [Full Text] [Related]  

  • 3. The determination of labetalol in plasma by high-performance liquid chromatography using fluorescence detection.
    Meredith PA; McSharry D; Elliott HL; Reid JL
    J Pharmacol Methods; 1981 Dec; 6(4):309-14. PubMed ID: 7334812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High pressure liquid chromatography on labetalol in serum or plasma.
    Woodman TF; Johnson B
    Ther Drug Monit; 1981; 3(4):371-5. PubMed ID: 7336471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of labetalol in human plasma by high-performance liquid chromatography.
    Dusci LJ; Hackett LP
    J Chromatogr; 1979 Jul; 175(1):208-10. PubMed ID: 546907
    [No Abstract]   [Full Text] [Related]  

  • 6. High-performance liquid chromatographic assay for labetalol in human plasma using a PRP-1 column and fluorometric detection.
    Alton KB; Leitz F; Bariletto S; Jaworsky L; Desrivieres D; Patrick J
    J Chromatogr; 1984 Nov; 311(2):319-28. PubMed ID: 6520179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of fluorescence detection for the determination of labetalol in plasma by high-performance liquid chromatography.
    Ostrovská V; Svobodová X; Pechová A; Kusala S; Svoboda M
    J Chromatogr; 1988 Jul; 446():323-7. PubMed ID: 3209660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of bufuralol and its major metabolites in plasma by high-performance liquid chromatography.
    Haefelfinger P
    J Chromatogr; 1980 Dec; 221(2):327-35. PubMed ID: 7217302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic assay of dilevalol, a beta-adrenoceptor blocker, in rat and human plasma.
    Dionisotti S; Bamonte F; Monopoli A
    J Chromatogr; 1990 Sep; 530(2):458-62. PubMed ID: 1981890
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitive high-performance liquid chromatographic method for the determination of labetalol diastereoisomers in plasma samples without derivatization.
    Grellet J; Michel-Gueroult P; Ducint D; Saux MC
    J Chromatogr; 1994 Jan; 652(1):59-66. PubMed ID: 8014228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paired-ion chromatography and high performance liquid chromatography of labetalol in feeds.
    Townley ER; Ross B
    J Assoc Off Anal Chem; 1980 Nov; 63(6):1262-5. PubMed ID: 7451388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labetalol steady-state pharmacokinetics in hypertensive patients.
    McNeil JJ; Anderson AE; Louis WJ; Raymond K
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):75S-80S. PubMed ID: 7093102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioreceptor assay for labetalol.
    Kelly JG; McGarry K; O'Malley K
    Br J Clin Pharmacol; 1981 Aug; 12(2):258-60. PubMed ID: 7306443
    [No Abstract]   [Full Text] [Related]  

  • 14. Mean steady-state plasma concentrations of labetalol in patients undergoing antihypertensive therapy.
    Sanders GL; Routledge PA; Ward A; Davies DM; Rawlins MD
    Br J Clin Pharmacol; 1979; 8(Suppl 2):153S-155S. PubMed ID: 526396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.
    McNeil JJ; Anderson AE; Louis WJ; Morgan DJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):157S-161S. PubMed ID: 526397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPLC separation technique for analysis of bufuralol enantiomers in plasma and pharmaceutical formulations using a vancomycin chiral stationary phase and UV detection.
    Hefnawy MM; Sultan MA; Al-Shehri MM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):328-36. PubMed ID: 17681871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of an automated sample processor and a polymer-based high-performance liquid chromatographic column to determine the pharmacokinetics of labetalol in man.
    Bates J; Carey PF; Godward RE
    J Chromatogr; 1987 Jun; 395():455-61. PubMed ID: 3624360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated sample preparation on-line with thermospray high-performance liquid chromatography-mass spectrometry for the determination of drugs in plasma.
    Lant MS; Oxford J; Martin LE
    J Chromatogr; 1987 May; 394(1):223-30. PubMed ID: 3597620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved liquid-chromatographic assay of labetalol in plasma.
    Luke DR; Matzke GR; Clarkson JT; Awni WM
    Clin Chem; 1987 Aug; 33(8):1450-2. PubMed ID: 3608164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorimetric and spectrophotometric determination of labetalol hydrochloride and its tablets.
    Mohamed ME
    Pharmazie; 1983 Nov; 38(11):784. PubMed ID: 6669606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.